BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND ETV6, TEL/ABL, 2120, ENSG00000139083, P41212, TEL
1019 results:

  • 1. Flow cytometric minimal residual disease measurement accounting for cytogenetics in children with non-high-risk acute lymphoblastic leukemia treated according to the ALL-MB 2008 protocol.
    Popov A; Henze G; Tsaur G; Budanov O; Roumiantseva J; Belevtsev M; Verzhbitskaya T; Movchan L; Lagoyko S; Zharikova L; Olshanskaya Y; Riger T; Valochnik A; Miakova N; Litvinov D; Khlebnikova O; Streneva O; Stolyarova E; Ponomareva N; Novichkova G; Aleinikova O; Fechina L; Karachunskiy A
    Cancer Med; 2024 Apr; 13(8):e7172. PubMed ID: 38651186
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Terminal deoxynucleotidyl transferase expression in different subtypes of childhood B-cell acute lymphoblastic leukemia.
    Yu CH; Su YH; Jou ST; Lu MY; Lin CY; Lin KH; Chang HH; Chou SW; Huang YH; Lin DT; Lin SW; Chen HY; Chang YH; Yang YL
    Pathol Res Pract; 2024 Apr; 256():155287. PubMed ID: 38579576
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Use of the etv6/RUNX1 probe to verify the performance of the fluorescence in situ hybridization probe before clinical detection].
    Xiao J; Zheng YC; Zhao JW; Cui CH; Wang HJ; Sun Q; Ma J; Ma YS; Song Z; Xiao ZJ; Li CW
    Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):48-53. PubMed ID: 38527838
    [No Abstract]    [Full Text] [Related]  

  • 4. [Multicenter evaluation of minimal residual disease monitoring in early induction therapy for treatment of childhood acute lymphoblastic leukemia].
    Wu XJ; Liao N; Mai HR; Li XY; Wan WQ; Yang LH; Huang LB; Luo XQ; Tian C; Chen QW; Long XJ; He YY; Wang Y; Li ZG; Xu HG
    Zhonghua Er Ke Za Zhi; 2024 Mar; 62(4):337-344. PubMed ID: 38527504
    [No Abstract]    [Full Text] [Related]  

  • 5. Integrated analysis of transcriptome and genome variations in pediatric T cell acute lymphoblastic leukemia: data from north Indian tertiary care center.
    Singh M; Sharma P; Bhatia P; Trehan A; Thakur R; Sreedharanunni S
    BMC Cancer; 2024 Mar; 24(1):325. PubMed ID: 38459434
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Clinical features and prognostic analysis of testicular relapse in pediatric acute lymphoblastic leukemia].
    Wang N; Gao YY; Qi BQ; Ruan M; Lyu H; Zhang XY; Zhang RR; Liu TF; Chen YM; Zou Y; Guo Y; Yang WY; Zhang L; Zhu XF; Chen XJ
    Zhonghua Er Ke Za Zhi; 2024 Mar; 62(3):262-267. PubMed ID: 38378289
    [No Abstract]    [Full Text] [Related]  

  • 7. Long noncoding RNA expression in acute lymphoblastic leukemia: A systematic review.
    Lobo-Alves SC; Oliveira LA; Kretzschmar GC; Valengo AE; Rosati R
    Crit Rev Oncol Hematol; 2024 Apr; 196():104290. PubMed ID: 38341118
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment.
    Buldini B; Varotto E; Maurer-Granofszky M; Gaipa G; Schumich A; Brüggemann M; Mejstrikova E; Cazzaniga G; Hrusak O; Szczepanowski M; Scarparo P; Zimmermann M; Strehl S; Schinnerl D; Zaliova M; Karawajew L; Bourquin JP; Feuerstein T; Cario G; Alten J; Möricke A; Biffi A; Parasole R; Fagioli F; Valsecchi MG; Biondi A; Locatelli F; Attarbaschi A; Schrappe M; Conter V; Basso G; Dworzak MN
    Blood; 2024 Apr; 143(17):1738-1751. PubMed ID: 38215390
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Combination of minimal residual disease on day 15 and copy number alterations results in BCR-abl1-negative pediatric B-ALL: A powerful tool for prediction of induction failure.
    Baghdadi H; Soleimani M; Zavvar M; Bahoush G; Poopak B
    Cancer Genet; 2024 Apr; 282-283():27-34. PubMed ID: 38183785
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Genetic Characterization of Pediatric Mixed Phenotype Acute Leukemia (MPAL).
    Panagopoulos I; Andersen K; Johannsdottir IMR; Tandsæther MR; Micci F; Heim S
    Cancer Genomics Proteomics; 2024; 21(1):1-11. PubMed ID: 38151288
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic Leukemia: Focus on the Genes Involved.
    Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Transcriptome Sequencing Allows Comprehensive Genomic Characterization of Pediatric B-Acute Lymphoblastic Leukemia in an Academic Clinical Laboratory.
    Hu Z; Kovach AE; Yellapantula V; Ostrow D; Doan A; Ji J; Schmidt RJ; Gu Z; Bhojwani D; Raca G
    J Mol Diagn; 2024 Jan; 26(1):49-60. PubMed ID: 37981088
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Next-Generation Sequencing of Vitreoretinal lymphoma by Vitreous Liquid Biopsy: Diagnostic Potential and Genotype/Phenotype Correlation.
    Kwak JJ; Lee KS; Lee J; Kim YJ; Choi EY; Byeon SH; Chang WS; Kim YR; Kim JS; Shin S; Lee ST; Kim SS; Lee CS
    Invest Ophthalmol Vis Sci; 2023 Nov; 64(14):27. PubMed ID: 37975847
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Synchronous presentation of
    Khera S; Kurup A; Agarwal S; Tripathi P
    BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37967932
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Presence of leukemic clone-specific immunoglobulin heavy chain rearrangements in neonatal blood spots of children with B-cell precursor acute lymphoblastic leukemia.
    Kacanski N; Kolarovic J; Kostic T; Marjanovic I; Janic D; Pavlovic S; Karan-Djurasevic T
    Int J Lab Hematol; 2024 Apr; 46(2):303-311. PubMed ID: 37929321
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Alternative genetic alterations of MYC, BCL2, and/or BCL6 in high-grade B-cell lymphoma (HGBL) and diffuse large B-cell lymphoma (DLBCL): Can we identify different prognostic subgroups?
    Blomme S; De Paepe P; Devos H; Emmerechts J; Snauwaert S; Cauwelier B
    Genes Chromosomes Cancer; 2024 Jan; 63(1):e23211. PubMed ID: 37897298
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A surrogate molecular approach for the detection of Philadelphia chromosome-like B-acute lymphoblastic leukemia.
    Gupta DG; Varma N; Abdulkadir SA; Sreedharanunni S; Sachdeva MUS; Naseem S; Bose P; Binota J; Malhotra P; Khadwal A; Trehan A; Varma S
    Cancer; 2024 Mar; 130(5):713-726. PubMed ID: 37819686
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Susceptibility of pediatric acute lymphoblastic leukemia to STAT3 inhibition depends on p53 induction.
    Gasparoli L; Virely C; Tsakaneli A; Che N; Edwards D; Bartram J; Hubank M; Pal D; Heidenreich O; Martens JHA; De Boer J; Williams O
    Haematologica; 2024 Apr; 109(4):1069-1081. PubMed ID: 37794795
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Leukemia Genotype Analysis of Children with Acute Lymphoblastic Leukemia in Yunnan Area].
    Shi SL; Kui LY; Xia SM; Zhou BL; Li RJ; Jiang HC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):980-984. PubMed ID: 37551465
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase fusion genes: A workshop report with focus on novel entities and a literature review including paediatric cases.
    Saft L; Kvasnicka HM; Boudova L; Gianelli U; Lazzi S; Rozman M
    Histopathology; 2023 Dec; 83(6):829-849. PubMed ID: 37551450
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 51.